Log In
BCIQ
Print this Print this
 

Augment Bone Graft (formerly GEM OS1)

  Manage Alerts
Collapse Summary General Information
Company Wright Medical Group N.V.
DescriptionCombination of recombinant human platelet derived growth factor BB (rhPDGFBB) and a resorbable synthetic bone matrix
Molecular Target Platelet derived growth factor receptor A (PDGFRA) (PDGFR2) (CD140A) ; Platelet derived growth factor receptor B (PDGFRB) (PDGFR1) (CD140B)
Mechanism of Action 
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationTissue replacement
Indication DetailsAlternative to the use of autograft in foot and ankle fusions; Treat distal radial fractures that require fusion; Treat foot and ankle fractures that require fusion
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$395.3M

$42.5M

$190.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/11/2013

$395.3M

$42.5M

$190.0M

Get a free BioCentury trial today